LV10448B - Substituted amide derivatives of piperazynilcamphorsulfonyloxytocin antagonists - Google Patents

Substituted amide derivatives of piperazynilcamphorsulfonyloxytocin antagonists Download PDF

Info

Publication number
LV10448B
LV10448B LVP-92-580A LV920580A LV10448B LV 10448 B LV10448 B LV 10448B LV 920580 A LV920580 A LV 920580A LV 10448 B LV10448 B LV 10448B
Authority
LV
Latvia
Prior art keywords
unsubstituted
substituted
substituent
alkyl
alkoxycarbonyl
Prior art date
Application number
LVP-92-580A
Other languages
English (en)
Latvian (lv)
Other versions
LV10448A (lv
Inventor
Mark G Bock
Jill M Erb
Doug W Hobbs
James B Hoffman
Debra S Perlow
Joseph M Pawluczyk
Daniel F Veber
Peter D Williams
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to HU9400738A priority Critical patent/HUT67287A/hu
Priority to PCT/US1992/007214 priority patent/WO1993006092A1/en
Priority to CS94561A priority patent/CZ56194A3/cs
Priority to SK287-94A priority patent/SK28794A3/sk
Priority to NZ244219A priority patent/NZ244219A/en
Priority to EP92202689A priority patent/EP0532097A1/en
Priority to IL103072A priority patent/IL103072A0/xx
Priority to CA002077922A priority patent/CA2077922A1/en
Priority to ZA926936A priority patent/ZA926936B/xx
Priority to MX9205216A priority patent/MX9205216A/es
Priority to CN92110672A priority patent/CN1070399A/zh
Priority to AU23550/92A priority patent/AU653059B2/en
Priority to JP4288091A priority patent/JP2523426B2/ja
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to LVP-92-580A priority patent/LV10448B/en
Priority to LTIP494A priority patent/LT3592B/lt
Priority to BG98644A priority patent/BG98644A/xx
Priority to FI941136A priority patent/FI941136A0/fi
Priority to NO940882A priority patent/NO940882D0/no
Publication of LV10448A publication Critical patent/LV10448A/xx
Priority to US08/451,779 priority patent/US5648352A/en
Publication of LV10448B publication Critical patent/LV10448B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/60—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/66—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-92-580A 1991-09-13 1992-12-30 Substituted amide derivatives of piperazynilcamphorsulfonyloxytocin antagonists LV10448B (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
HU9400738A HUT67287A (en) 1991-09-13 1992-08-26 Piperazynil camphor derivatives and pharmaceutical compositions containing them
PCT/US1992/007214 WO1993006092A1 (en) 1991-09-13 1992-08-26 Piperazinyl (sulfonyl)amide derivatives of camphor as oxytocin antagonists
CS94561A CZ56194A3 (en) 1991-09-13 1992-08-26 Derivatives of piperazinyl(sulfonyl) amide of camphor as oxytocin antagonists
SK287-94A SK28794A3 (en) 1991-09-13 1992-08-26 Piperazinyl(sulfonyl) amide derivatives of camphor as oxytocin antagonists
NZ244219A NZ244219A (en) 1991-09-13 1992-09-04 Piperazinyl(sulphon)amide camphor derivatives and pharmaceutical compositions
EP92202689A EP0532097A1 (en) 1991-09-13 1992-09-05 Piperazinyl(sulfon)amide derivatives of camphor as oxytocin antagonists
IL103072A IL103072A0 (en) 1991-09-13 1992-09-07 Substituted amide derivatives of piperazinyl-camphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them
CA002077922A CA2077922A1 (en) 1991-09-13 1992-09-10 Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
MX9205216A MX9205216A (es) 1991-09-13 1992-09-11 Derivados de amida substituida de antagonistas de piperizinilcan-forsulfonil oxitocina
ZA926936A ZA926936B (en) 1991-09-13 1992-09-11 Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
CN92110672A CN1070399A (zh) 1991-09-13 1992-09-11 哌嗪基樟脑磺酰基取代的酰胺衍生物催产素拮抗剂
AU23550/92A AU653059B2 (en) 1991-09-13 1992-09-11 Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
JP4288091A JP2523426B2 (ja) 1991-09-13 1992-09-14 ピペリジニル樟脳スルホニルオキシトシン拮抗剤の置換アミド誘導体
LVP-92-580A LV10448B (en) 1991-09-13 1992-12-30 Substituted amide derivatives of piperazynilcamphorsulfonyloxytocin antagonists
LTIP494A LT3592B (en) 1991-09-13 1993-04-27 Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
BG98644A BG98644A (en) 1991-09-13 1994-03-09 Piperazinyl (sulphonyl) amide derivatives of the camphor as oxytocin antagonists
FI941136A FI941136A0 (fi) 1991-09-13 1994-03-10 Kamferin piperatsinyyli(sulfonyyli)amidijohdannaiset oksitosiiniantagonisteina
NO940882A NO940882D0 (no) 1991-09-13 1994-03-11 Piperazinyl-(sulfonyl)-amidderivater av kamfer som oxytocinantagonister
US08/451,779 US5648352A (en) 1991-09-13 1995-05-26 Piperazinylcamphorsulfonyl oxytocin antagonists

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75924291A 1991-09-13 1991-09-13
US91754992A 1992-07-21 1992-07-21
LVP-92-580A LV10448B (en) 1991-09-13 1992-12-30 Substituted amide derivatives of piperazynilcamphorsulfonyloxytocin antagonists

Publications (2)

Publication Number Publication Date
LV10448A LV10448A (lv) 1995-02-20
LV10448B true LV10448B (en) 1995-10-20

Family

ID=30118940

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-580A LV10448B (en) 1991-09-13 1992-12-30 Substituted amide derivatives of piperazynilcamphorsulfonyloxytocin antagonists

Country Status (15)

Country Link
EP (1) EP0532097A1 (fi)
JP (1) JP2523426B2 (fi)
CN (1) CN1070399A (fi)
AU (1) AU653059B2 (fi)
BG (1) BG98644A (fi)
CA (1) CA2077922A1 (fi)
CZ (1) CZ56194A3 (fi)
FI (1) FI941136A0 (fi)
HU (1) HUT67287A (fi)
IL (1) IL103072A0 (fi)
LV (1) LV10448B (fi)
MX (1) MX9205216A (fi)
NZ (1) NZ244219A (fi)
SK (1) SK28794A3 (fi)
WO (1) WO1993006092A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648352A (en) * 1991-09-13 1997-07-15 Merck & Co., Inc. Piperazinylcamphorsulfonyl oxytocin antagonists
EP0614894A1 (en) * 1993-03-12 1994-09-14 Merck & Co. Inc. Process for the synthesis of substituted amide derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
WO1995002587A1 (en) * 1993-07-16 1995-01-26 Merck & Co., Inc. Substituted piperazinylcamphor derivatives as oxytocin antagonists
US5464788A (en) * 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5599809A (en) * 1994-09-29 1997-02-04 Merck & Co., Inc. Method for improving reproductive efficiency in farm animals
WO1996012476A1 (en) * 1994-10-20 1996-05-02 Merck & Co., Inc. Wet granulation formulation for a piperazinylcamphorsulfonyl oxytocin receptor antagonist
US5656606A (en) * 1995-02-17 1997-08-12 Merck & Co., Inc. Camphor compounds promote release of growth hormone
US6268359B1 (en) 1998-01-28 2001-07-31 Senju Pharmaceutical Co., Ltd. Preventives or remedies for vision disorders
GB0130677D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd Medicaments and novel compounds
CN101007794B (zh) * 2006-01-26 2010-09-01 中国科学院上海药物研究所 N,n'-二取代哌嗪类衍生物及其制备方法、药物组合物和用途
CN108689996B (zh) * 2017-03-29 2021-06-29 江苏恒瑞医药股份有限公司 氮杂环丁基甲酰胺类衍生物、其制备方法及其在医药上的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1228454B (it) * 1989-02-22 1991-06-19 Roussel Maestretti S P A Milan Derivati del 1-arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci.
CA2037287A1 (en) * 1990-03-02 1991-09-03 Ben E. Evans Spirocyclic oxytocin antagonists
IL99957A0 (en) * 1990-11-13 1992-08-18 Merck & Co Inc Piperidinylcamphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2077922A1 (en) 1993-03-14
JPH07242625A (ja) 1995-09-19
CZ56194A3 (en) 1995-06-14
BG98644A (en) 1995-03-31
FI941136A (fi) 1994-03-10
EP0532097A1 (en) 1993-03-17
HUT67287A (en) 1995-03-28
WO1993006092A1 (en) 1993-04-01
SK28794A3 (en) 1995-07-11
JP2523426B2 (ja) 1996-08-07
LV10448A (lv) 1995-02-20
MX9205216A (es) 1993-03-01
CN1070399A (zh) 1993-03-31
FI941136A0 (fi) 1994-03-10
NZ244219A (en) 1995-08-28
AU2355092A (en) 1993-03-25
IL103072A0 (en) 1993-02-21
HU9400738D0 (en) 1994-06-28
AU653059B2 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
CA2078025A1 (en) Substituted amine derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
CA2078264A1 (en) Substituted derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
DE68905272T2 (de) Cycloalkyl-substituierte glutaramide als antihypertensika.
DE60021371T2 (de) Piperidinderivate verwendbar als ccr5 antagonisten
US5756504A (en) Tocolytic oxytocin receptor antagonists
ZA200202593B (en) Cyclic amine compounds as CCR5 antagonists.
CA2078265A1 (en) Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
CA1242439A (en) 1-¬(AMINOALKYL AND AMINOALKYLAMINO)CARBONYL AND THIOCARBONYL|-.alpha.,.alpha.-DIARYLPYRROLIDINE, PIPERIDINE AND HOMOPIPERIDINEACETAMIDES AND ACETONITRILES
AU675730B2 (en) Substituted piperazinylcamphor derivatives as oxytocin antagonists
LV10448B (en) Substituted amide derivatives of piperazynilcamphorsulfonyloxytocin antagonists
EP0444945A2 (en) Use of spirocyclic compounds as oxytocin antagonists
EP0450761A1 (en) Spirocyclic oxytocin antagonists
JP2004513063A (ja) 細胞接着阻害抗炎症および免疫抑制化合物
CA2174650A1 (en) Piperidinyl camphorsulfonyl oxytocin antagonists
EP0361791B1 (en) Azacyclic derivatives useful as medicaments
US3864348A (en) 1-Oxa-3,8-diaza spiro (4,5) decane compounds
US5332732A (en) Thiophene and pyridine antipsychotic agents
US6787650B1 (en) Urea compounds, process for producing the same and use thereof
CA2078263A1 (en) Substituted alkyl derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
US5648352A (en) Piperazinylcamphorsulfonyl oxytocin antagonists
NO790568L (no) Fremgangsmaate for fremstilling av halogensubstituerte merkaptoacylaminosyrer
LT3592B (en) Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists
US3423415A (en) 4 - (n - (3,3 - diphenyl - propyl) - amino) - 1-methyl-3-phenyl-piperidine and intermediates thereto
IE47898B1 (en) Substituted n-iminomethylpiperidines
IE42644B1 (en) (indolin-1-yl)-guanidines